CoChat
Sign Up
Cited by 74

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Central Role of ULK1 in Type I Interferon Signaling

Saleiro, Diana, Mehrotra, Swarna, Kroczynska, Barbara, Beauchamp, Elspeth M., Lisowski, Pawel, Majchrzak-Kita, Beata, Bhagat, Tushar D., Stein, Brady L., McMahon, Brandon, Altman, Jessica K., Kosciuczuk, Ewa M., Baker, Darren P., Jie, Chunfa, Jafari, Nadereh, Thompson, Craig B., Levine, Ross L., Fish, Eleanor N., Verma, Amit K., Platanias, Leonidas C.·2015·Cell Reports
DOI 10.1016/j.celrep.2015.03.056PMC PMC4477687
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2015.03.056

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Alers, 2012, The incredible ULKs, Cell Commun. Signal., 10, 7, 10.1186/1478-811X-10-7 · DOI
  2. Alp, 2004, Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease, Arterioscler. Thromb. Vasc. Biol., 24, 413, 10.1161/01.ATV.0000110785.96039.f6 · DOI
  3. Ambjørn, 2013, IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function, Autophagy, 9, 287, 10.4161/auto.22831 · DOI
  4. Bach, 2011, The serine/threonine kinase ULK1 is a target of multiple phosphorylation events, Biochem. J., 440, 283, 10.1042/BJ20101894 · DOI · Paper page
  5. Bekisz, 2013, Immunomodulatory effects of interferons in malignancies, J. Interferon Cytokine Res., 33, 154, 10.1089/jir.2012.0167 · DOI
  6. Borden, 2007, Interferons at age 50: past, current and future impact on biomedicine, Nat. Rev. Drug Discov., 6, 975, 10.1038/nrd2422 · DOI · Paper page
  7. Cassinat, 2014, Interferon alfa therapy in CALR-mutated essential thrombocythemia, N. Engl. J. Med., 371, 188, 10.1056/NEJMc1401255 · DOI
  8. Cheon, 2014, Interferons and their stimulated genes in the tumor microenvironment, Semin. Oncol., 41, 156, 10.1053/j.seminoncol.2014.02.002 · DOI
  9. Cheong, 2011, Ammonia-induced autophagy is independent of ULK1/ULK2 kinases, Proc. Natl. Acad. Sci. USA, 108, 11121, 10.1073/pnas.1107969108 · DOI
  10. Colina, 2008, Translational control of the innate immune response through IRF-7, Nature, 452, 323, 10.1038/nature06730 · DOI
  11. de Weerd, 2013, Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1, Nat. Immunol., 14, 901, 10.1038/ni.2667 · DOI
  12. Egan, 2011, Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy, Science, 331, 456, 10.1126/science.1196371 · DOI · Paper page
  13. Gall, 2012, Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease, Immunity, 36, 120, 10.1016/j.immuni.2011.11.018 · DOI · Paper page
  14. García, 2006, Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action, Microbiol. Mol. Biol. Rev., 70, 1032, 10.1128/MMBR.00027-06 · DOI · Paper page
  15. González-Navajas, 2012, Immunomodulatory functions of type I interferons, Nat. Rev. Immunol., 12, 125, 10.1038/nri3133 · DOI
  16. Hervas-Stubbs, 2011, Direct effects of type I interferons on cells of the immune system, Clin. Cancer Res., 17, 2619, 10.1158/1078-0432.CCR-10-1114 · DOI
  17. Honda, 2005, IRF-7 is the master regulator of type-I interferon-dependent immune responses, Nature, 434, 772, 10.1038/nature03464 · DOI
  18. Hunn, 2008, Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii, EMBO J., 27, 2495, 10.1038/emboj.2008.176 · DOI
  19. Ivashkiv, 2014, Regulation of type I interferon responses, Nat. Rev. Immunol., 14, 36, 10.1038/nri3581 · DOI
  20. Joshi, 2009, Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses, Proc. Natl. Acad. Sci. USA, 106, 12097, 10.1073/pnas.0900562106 · DOI
  21. Kaur, 2013, IFN-β-specific signaling via a unique IFNAR1 interaction, Nat. Immunol., 14, 884, 10.1038/ni.2686 · DOI
  22. Kaur, 2007, Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling, J. Biol. Chem., 282, 1757, 10.1074/jbc.M607365200 · DOI
  23. Kaur, 2008, Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling, J. Immunol., 181, 7316, 10.4049/jimmunol.181.10.7316 · DOI
  24. Kaur, 2008, Role of the Akt pathway in mRNA translation of interferon-stimulated genes, Proc. Natl. Acad. Sci. USA, 105, 4808, 10.1073/pnas.0710907105 · DOI
  25. Kaur, 2012, Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses, Proc. Natl. Acad. Sci. USA, 109, 7723, 10.1073/pnas.1118122109 · DOI
  26. Kaur, 2014, Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses, J. Biol. Chem., 289, 6581, 10.1074/jbc.M113.537852 · DOI
  27. Kiladjian, 2011, The renaissance of interferon therapy for the treatment of myeloid malignancies, Blood, 117, 4706, 10.1182/blood-2010-08-258772 · DOI
  28. Kim, 2011, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat. Cell Biol., 13, 132, 10.1038/ncb2152 · DOI · Paper page
  29. Klionsky, 2008, Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?, Autophagy, 4, 849, 10.4161/auto.6845 · DOI · Paper page
  30. Konno, 2013, Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling, Cell, 155, 688, 10.1016/j.cell.2013.09.049 · DOI · Paper page
  31. Kotredes, 2013, Interferons as inducers of apoptosis in malignant cells, J. Interferon Cytokine Res., 33, 162, 10.1089/jir.2012.0110 · DOI
  32. Kroczynska, 2009, Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals, Mol. Cell. Biol., 29, 2865, 10.1128/MCB.01537-08 · DOI
  33. Kroczynska, 2012, Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses, Mol. Cell. Biol., 32, 2809, 10.1128/MCB.00310-12 · DOI
  34. Kroczynska, 2014, Regulation of interferon-dependent mRNA translation of target genes, J. Interferon Cytokine Res., 34, 289, 10.1089/jir.2013.0148 · DOI
  35. Kundu, 2008, Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation, Blood, 112, 1493, 10.1182/blood-2008-02-137398 · DOI
  36. Lenschow, 2007, IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses, Proc. Natl. Acad. Sci. USA, 104, 1371, 10.1073/pnas.0607038104 · DOI
  37. Li, 2004, Role of p38alpha Map kinase in Type I interferon signaling, J. Biol. Chem., 279, 970, 10.1074/jbc.M309927200 · DOI
  38. Li, 2005, Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons, J. Biol. Chem., 280, 10001, 10.1074/jbc.M410972200 · DOI
  39. Liu, 2011, IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1, J. Immunol., 187, 2559, 10.4049/jimmunol.1100963 · DOI
  40. Lu, 2010, Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway, Exp. Hematol., 38, 472, 10.1016/j.exphem.2010.03.005 · DOI
  41. Mack, 2012, AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization, Autophagy, 8, 1197, 10.4161/auto.20586 · DOI
  42. Mayer, 2001, The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells, J. Biol. Chem., 276, 28570, 10.1074/jbc.M011685200 · DOI
  43. McAllister, 2009, The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors, J. Biol. Chem., 284, 1644, 10.1074/jbc.M807888200 · DOI
  44. Mehrotra, 2013, Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors, J. Biol. Chem., 288, 23814, 10.1074/jbc.M113.476192 · DOI
  45. Mizushima, 2001, Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells, J. Cell Biol., 152, 657, 10.1083/jcb.152.4.657 · DOI · Paper page
  46. Peng, 2003, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2, Genes Dev., 17, 1352, 10.1101/gad.1089403 · DOI
  47. Platanias, 2005, Mechanisms of type-I- and type-II-interferon-mediated signalling, Nat. Rev. Immunol., 5, 375, 10.1038/nri1604 · DOI
  48. Platanias, 2013, Interferons and their antitumor properties, J. Interferon Cytokine Res., 33, 143, 10.1089/jir.2013.0019 · DOI
  49. Rampal, 2014, Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis, Blood, 123, e123, 10.1182/blood-2014-02-554634 · DOI
  50. Rani, 2007, Novel interferon-beta-induced gene expression in peripheral blood cells, J. Leukoc. Biol., 82, 1353, 10.1189/jlb.0507273 · DOI
  51. Russell, 2013, ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase, Nat. Cell Biol., 15, 741, 10.1038/ncb2757 · DOI · Paper page
  52. Schmeisser, 2010, Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene, J. Virol., 84, 10671, 10.1128/JVI.00818-10 · DOI
  53. Schmeisser, 2014, New function of type I IFN: induction of autophagy, J. Interferon Cytokine Res., 34, 71, 10.1089/jir.2013.0128 · DOI
  54. Sharma, 2003, Triggering the interferon antiviral response through an IKK-related pathway, Science, 300, 1148, 10.1126/science.1081315 · DOI
  55. Stark, 2012, The JAK-STAT pathway at twenty, Immunity, 36, 503, 10.1016/j.immuni.2012.03.013 · DOI
  56. Stein, 2013, Biological rationale and clinical use of interferon in the classical BCR-ABL-negative myeloproliferative neoplasms, J. Interferon Cytokine Res., 33, 145, 10.1089/jir.2012.0120 · DOI
  57. Tefferi, 2011, Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies, J. Clin. Oncol., 29, 573, 10.1200/JCO.2010.29.8711 · DOI
  58. Uddin, 1999, Activation of the p38 mitogen-activated protein kinase by type I interferons, J. Biol. Chem., 274, 30127, 10.1074/jbc.274.42.30127 · DOI
  59. Uddin, 2000, The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins, J. Biol. Chem., 275, 27634, 10.1074/jbc.M003170200 · DOI
  60. van Boxel-Dezaire, 2006, Complex modulation of cell type-specific signaling in response to type I interferons, Immunity, 25, 361, 10.1016/j.immuni.2006.08.014 · DOI · Paper page
  61. Yang, 2012, Crystal structure of ISG54 reveals a novel RNA binding structure and potential functional mechanisms, Cell Res., 22, 1328, 10.1038/cr.2012.111 · DOI
  62. Zhang, 2005, Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression, Mol. Cell. Biol., 25, 6247, 10.1128/MCB.25.14.6247-6258.2005 · DOI
  63. Zhu, 2014, Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor, Immunity, 40, 936, 10.1016/j.immuni.2014.05.007 · DOI

Cited by

Sorted by citations

See all 74

Metadata

Authors
Saleiro, D., Mehrotra, S., Kroczynska, B., Beauchamp, E. M., Lisowski, P., Majchrzak-Kita, B., Bhagat, T. D., Stein, B. L., McMahon, B., Altman, J. K., Kosciuczuk, E. M., Baker, D. P., Jie, C., Jafari, N., Thompson, C. B., Levine, R. L., Fish, E. N., Verma, A. K., & Platanias, L. C.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2015-04
Volume
11
Issue
4
Pages
605-617
ISSN
2211-1247
DOI
10.1016/j.celrep.2015.03.056
PMC
PMC4477687
Cited by
74
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review